Chargement en cours...
The legal imperative for treating rare disorders
BACKGROUND: Life-saving orphan drugs are some of the most expensive medicines. European Union governments aim to accommodate their provision within stretched healthcare budgets but face pressure to reduce funding of such treatments. Patients struggle to retain or gain access to them as their special...
Enregistré dans:
| Auteurs principaux: | , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
BioMed Central
2013
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4016581/ https://ncbi.nlm.nih.gov/pubmed/24010951 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1750-1172-8-135 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|